Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | dna polymerase kappa | 0.0021 | 0.1847 | 0.0183 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0021 | 0.1847 | 1 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0034 | 0.5597 | 0.4874 |
Giardia lamblia | DINP protein human, muc B family | 0.0021 | 0.1847 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.0189 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0034 | 0.5597 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.002 | 0.1695 | 0.5 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.0189 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0021 | 0.1847 | 1 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0021 | 0.1847 | 0.0183 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0021 | 0.1847 | 0.0183 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.002 | 0.1695 | 0.1747 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0.1847 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0048 | 0.9701 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 1 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0021 | 0.1847 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0021 | 0.1847 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0048 | 0.9701 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.9701 | 0.964 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0021 | 0.1847 | 0.0183 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.0189 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0048 | 0.9701 | 0.964 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0021 | 0.1847 | 0.1904 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0048 | 0.9701 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.005 | 1 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.1695 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 1 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0034 | 0.5597 | 0.4874 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0021 | 0.1847 | 0.1904 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 1 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0021 | 0.1847 | 0.0183 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0021 | 0.1847 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0021 | 0.1847 | 1 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.002 | 0.1695 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.005 | 1 | 1 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0021 | 0.1847 | 0.0189 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0021 | 0.1847 | 0.0183 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Echinococcus granulosus | dna polymerase kappa | 0.0021 | 0.1847 | 0.0183 |
Trypanosoma brucei | unspecified product | 0.0021 | 0.1847 | 0.1904 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0021 | 0.1847 | 0.0183 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.0189 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.0189 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.005 | 1 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.0048 | 0.9701 | 0.964 |
Schistosoma mansoni | DNA polymerase eta | 0.0048 | 0.9701 | 0.964 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.002 | 0.1695 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0021 | 0.1847 | 0.1904 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.005 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0021 | 0.1847 | 0.1904 |
Echinococcus multilocularis | dna polymerase eta | 0.0048 | 0.9701 | 0.964 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.